Henze Meg, Brown Suzanne J, Hadlow Narelle C, Walsh John P
King Edward Memorial Hospital, Subiaco, Western Australia 6008, Australia.
Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia 6009, Australia.
J Clin Endocrinol Metab. 2017 Nov 1;102(11):4235-4241. doi: 10.1210/jc.2017-01322.
Thyroid function testing often uses thyrotropin (TSH) measurement first, followed by reflex testing for free thyroxine (T4) if TSH is outside the reference range. The utility of different TSH cutoffs for reflex testing is unknown.
To examine different TSH cutoffs for reflex free T4 testing.
DESIGN, SETTING, AND PATIENTS: We analyzed concurrent TSH and free T4 results from 120,403 individuals from a single laboratory in Western Australia (clinical cohort) and 4568 Busselton Health Study participants (community cohort).
In the clinical cohort, restricting free T4 measurement to individuals with TSH <0.3 or >5.0 mU/L resulted in a 22% reduction in free T4 testing compared with a TSH reference range of 0.4 to 4.0 mU/L; using TSH cutoffs of 0.2 and 6.0 mU/L resulted in a 34% reduction in free T4 testing. In the community cohort, the corresponding effect was less: 3.3% and 4.8% reduction in free T4 testing. In the clinical cohort, using TSH cutoffs of 0.2 and 6.0 mU/L, elevated free T4 would go undetected in 4.2% of individuals with TSH levels of 0.2 to 0.4 mU/L. In most, free T4 was marginally elevated and unlikely to indicate clinically relevant hyperthyroidism. Low free T4 would go undetected in 2.5% of individuals with TSH levels of 4 to 6 mU/L; in 94%, free T4 was marginally reduced and unlikely to indicate clinically relevant hypothyroidism.
Setting TSH cutoffs at 0.1 to 0.2 mU/L less than and 1 to 2 mU/L greater than the reference range for reflex testing of free T4 would reduce the need for free T4 testing, with minimal effect on case finding.
甲状腺功能检测通常首先检测促甲状腺激素(TSH),如果TSH超出参考范围,则进一步检测游离甲状腺素(T4)。不同TSH临界值用于进一步检测的效用尚不清楚。
研究用于游离T4进一步检测的不同TSH临界值。
设计、研究地点与患者:我们分析了来自西澳大利亚一个实验室的120403名个体(临床队列)以及4568名巴瑟尔顿健康研究参与者(社区队列)的TSH和游离T4同步检测结果。
在临床队列中,将游离T4检测限制在TSH<0.3或>5.0 mU/L的个体,与TSH参考范围为0.4至4.0 mU/L相比,游离T4检测减少了22%;使用TSH临界值0.2和6.0 mU/L,游离T4检测减少了34%。在社区队列中,相应的影响较小:游离T4检测分别减少了3.3%和4.8%。在临床队列中,使用TSH临界值0.2和6.0 mU/L时,TSH水平为0.2至0.4 mU/L的个体中有4.2%的人游离T4升高未被检测到。大多数情况下,游离T4只是略有升高,不太可能提示临床相关的甲状腺功能亢进。TSH水平为4至6 mU/L的个体中有2.5%的人游离T4降低未被检测到;94%的人游离T4只是略有降低,不太可能提示临床相关的甲状腺功能减退。
将用于游离T4进一步检测的TSH临界值设定为比参考范围低0.1至0.2 mU/L和高1至2 mU/L,将减少游离T4检测的需求,对病例发现的影响最小。